InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Thursday, 05/23/2019 8:50:39 AM

Thursday, May 23, 2019 8:50:39 AM

Post# of 639
News: $NLNK NewLink Genetics Presents Updated NLG802 Results at the Immuno-Oncology 2019 World Congress

NLG802, a prodrug of indoximod, produced significantly higher pharmacokinetic (PK) exposure in patients compared to molar equivalent of indoximod while maintaining encouraging safety profile Notable response in 5 th line pancreatic cancer patient re-challenged with chemotherapy after ...

Find out more https://marketwirenews.com/news-releases/newlink-genetics-presents-updated-nlg802-results-at-the-immuno-oncology-2019-world-congress-8234968.html